Marta Vázquez

1.4k total citations
67 papers, 872 citations indexed

About

Marta Vázquez is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Marta Vázquez has authored 67 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pediatrics, Perinatology and Child Health, 20 papers in Psychiatry and Mental health and 14 papers in Pharmacology. Recurrent topics in Marta Vázquez's work include Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (17 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Marta Vázquez is often cited by papers focused on Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (17 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Marta Vázquez collaborates with scholars based in Uruguay, Spain and Chile. Marta Vázquez's co-authors include Pietro Fagiolino, Vicenta Devesa, Dinoraz Vélez, Cecilia Maldonado, Manuel Ibarra, Marta Calatayud, Hartmut Derendorf, Sandra Orozco‐Suárez, I. Cánovas Olmos and Beatriz de la Fuente and has published in prestigious journals such as SHILAP Revista de lepidopterología, Proteins Structure Function and Bioinformatics and Food and Chemical Toxicology.

In The Last Decade

Marta Vázquez

62 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Vázquez Uruguay 18 236 228 161 151 106 67 872
Lewis Couchman United Kingdom 21 100 0.4× 294 1.3× 53 0.3× 289 1.9× 38 0.4× 63 1.4k
Alain Turcant France 19 132 0.6× 103 0.5× 45 0.3× 164 1.1× 149 1.4× 98 1.3k
M. Rodamilans Spain 19 88 0.4× 69 0.3× 341 2.1× 116 0.8× 67 0.6× 44 938
Savita Verma Attri India 19 169 0.7× 63 0.3× 84 0.5× 182 1.2× 94 0.9× 115 1.2k
Norbert Felgenhauer Germany 20 108 0.5× 123 0.5× 270 1.7× 95 0.6× 26 0.2× 52 1.2k
Grzegorz Buszewicz Poland 19 71 0.3× 45 0.2× 133 0.8× 217 1.4× 55 0.5× 74 1.2k
Francis M. Urry United States 17 106 0.4× 82 0.4× 47 0.3× 297 2.0× 36 0.3× 28 1.0k
Souleiman El Balkhi France 18 67 0.3× 78 0.3× 307 1.9× 110 0.7× 51 0.5× 69 955
Hae Dong Woo South Korea 22 38 0.2× 75 0.3× 226 1.4× 405 2.7× 172 1.6× 48 1.4k
A Marzo Italy 21 201 0.9× 67 0.3× 27 0.2× 291 1.9× 75 0.7× 122 1.4k

Countries citing papers authored by Marta Vázquez

Since Specialization
Citations

This map shows the geographic impact of Marta Vázquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Vázquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Vázquez more than expected).

Fields of papers citing papers by Marta Vázquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Vázquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Vázquez. The network helps show where Marta Vázquez may publish in the future.

Co-authorship network of co-authors of Marta Vázquez

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Vázquez. A scholar is included among the top collaborators of Marta Vázquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Vázquez. Marta Vázquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maldonado, Cecilia, et al.. (2024). Aplicación de un modelo farmacocinético poblacional para el seguimiento de pacientes en tratamiento con dolutegravir. Revista Médica del Uruguay. 40(1). e202–e202.
2.
3.
Vázquez, Marta, et al.. (2024). Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report. Transplantation Proceedings. 56(1). 252–256. 1 indexed citations
4.
Maldonado, Cecilia, et al.. (2023). Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation. European Journal of Pharmaceutical Sciences. 183. 106399–106399. 4 indexed citations
5.
Schoretsanitis, Georgios, Robert L. Smith, Espen Molden, et al.. (2021). European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed. Journal of Clinical Psychopharmacology. 41(2). 140–147. 19 indexed citations
6.
Maldonado, Cecilia, et al.. (2020). Pharmacokinetics of Subcutaneous Levetiracetam in Palliative Care Patients. Journal of Palliative Medicine. 24(2). 248–251. 6 indexed citations
7.
Feria-Romero, Iris A., Héctor Serrano, Pietro Fagiolino, et al.. (2017). Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy. Pharmacological Reports. 69(3). 504–511. 46 indexed citations
8.
Ibarra, Manuel, et al.. (2016). Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets. European Journal of Pharmaceutical Sciences. 85. 106–111. 10 indexed citations
9.
10.
Ibarra, Manuel, et al.. (2015). A simple pharmacokinetic model based on mean residence times to predict furosemide exposure after oral doses.. International Journal of Pharmacy and Pharmaceutical Sciences. 3(4). 54–65. 2 indexed citations
11.
Vázquez, Marta, Dinoraz Vélez, Vicenta Devesa, & Sergi Puig. (2015). Participation of divalent cation transporter DMT1 in the uptake of inorganic mercury. Toxicology. 331. 119–124. 28 indexed citations
12.
Ibarra, Manuel, et al.. (2015). Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 41(6). 787–793. 14 indexed citations
13.
Vázquez, Marta, et al.. (2014). Experiencia Uruguaya en Atención Farmacéutica activa en la comunidad. Revista cubana de farmacia. 48(1). 63–72. 1 indexed citations
14.
Fagiolino, Pietro, et al.. (2014). Chronic administration of phenytoin induces efflux transporter overexpression in rats. Pharmacological Reports. 66(6). 946–951. 19 indexed citations
15.
Vázquez, Marta, Marta Calatayud, Dinoraz Vélez, & Vicenta Devesa. (2013). Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells. Toxicology. 311(3). 147–153. 36 indexed citations
16.
Fagiolino, Pietro, et al.. (2013). Clearance and bioavailability study through arterio-venous drug concentrations relationship. European Journal of Pharmaceutical Sciences. 48(4-5). 825–829. 6 indexed citations
17.
Vázquez, Marta, Pietro Fagiolino, & Eduardo L. Mariño. (2013). Concentration-Dependent Mechanisms of Adverse Drug Reactions in Epilepsy. Current Pharmaceutical Design. 19(38). 6802–6808. 6 indexed citations
18.
Maldonado, Cecilia, et al.. (2011). Time-dependent and concentration -dependent upregulation of carbamazepine efflux transporter: a preliminary assessment from salivary drug monitoring. Latin American Journal of Pharmacy. 4 indexed citations
19.
Fagiolino, Pietro, et al.. (2011). Influence of Efflux Transporters on Drug Metabolism. Clinical Pharmacokinetics. 50(2). 75–80. 12 indexed citations
20.
Vázquez, Marta, et al.. (1998). Chronopharmacocinétique de la carbamazépine et de son métabolite 10.11 époxide. Journal de Pharmacie Clinique. 17(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lewis Couchman Breakdown of academic impact, for papers by Alain Turcant Breakdown of academic impact, for papers by M. Rodamilans Breakdown of academic impact, for papers by Savita Verma Attri Breakdown of academic impact, for papers by Norbert Felgenhauer Breakdown of academic impact, for papers by Grzegorz Buszewicz Breakdown of academic impact, for papers by Francis M. Urry Breakdown of academic impact, for papers by Souleiman El Balkhi Breakdown of academic impact, for papers by Hae Dong Woo Breakdown of academic impact, for papers by A Marzo
Rankless by CCL
2026